Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5860

4DMT licenses eye gene therapy to Otsuka in Asia-Pacific; Arcus’ $250M offering

$
0
0
Plus, news about Galapagos, Nanobiotix, AstraZeneca, NovaBridge Biosciences, Corbus and Contineum Therapeutics: 👁️ 4D Molecular Therapeutics, Otsuka inks Asia-Pacific deal: The biotech is getting $85 million upfront, with up to ...

Viewing all articles
Browse latest Browse all 5860

Trending Articles